Cited by 887Nanoparticle-Based Drug DeliveryInnovative Microfluidic and Catalytic Techniques InnovationMicrofluidic and Capillary Electrophoresis Applications

Microfluidic Platform for Controlled Synthesis of Polymeric Nanoparticles

Karnik, Rohit, Gu, Frank, Basto, Pamela, Cannizzaro, Christopher, Dean, Lindsey, Kyei-Manu, William, Langer, Robert, Farokhzad, Omid C.·2008·Nano Letters

Abstract

A central challenge in the development of drug-encapsulated polymeric nanoparticles is the inability to control the mixing processes required for their synthesis resulting in variable nanoparticle physicochemical properties. Nanoparticles may be developed by mixing and nanoprecipitation of polymers and drugs dissolved in organic solvents with nonsolvents. We used rapid and tunable mixing through hydrodynamic flow focusing in microfluidic channels to control nanoprecipitation of poly(lactic- co-glycolic acid)- b-poly(ethylene glycol) diblock copolymers as a model polymeric biomaterial for drug delivery. We demonstrate that by varying (1) flow rates, (2) polymer composition, and (3) polymer concentration we can optimize the size, improve polydispersity, and control drug loading and release of the resulting nanoparticles. This work suggests that microfluidics may find applications for the development and optimization of polymeric nanoparticles in the newly emerging field of nanomedicine.

Integrity signals

Registry

Crossref · 10.1021/nl801736q

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • High-precision microfluidic and micropatterning techniques for the production of highly mono-disperse nanoparticles with uniform physicochemical properties and greatly reduced batch-to-batch variability are rapidly gaining attention.

    “Compared with bulk-synthesis techniques that largely rely on solution-based chemistry, high-precision microfluidic and micropatterning techniques for the production of highly mono-disperse nanoparticles with uniform physicochemical properties and greatly reduced batch-to-batch variability are rapidly gaining attention90,91.”
  • In recent years, progress has been made in producing more controlled formulations with size and composition levels compatible with microfluidic systems.

    “In the last years, progress has been made in producing more controlled formulations with size and composition levels compatible with microfluidic systems133”
  • Lipid nanoparticle-mRNA formulations manufactured by rapid mixing exhibit a stable nanostructure, in which mRNA molecules can be encapsulated in the interior core through electrostatic interactions with the lipids.

    “Lipid nanoparticle–mRNA formulations manufactured by rapid mixing exhibit a stable nanostructure17,130,131, in which mRNA molecules can be encapsulated in the interior core through electrostatic interactions with the lipids17,131.”

    From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [130]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Karnik, R., Gu, F., Basto, P., Cannizzaro, C., Dean, L., Kyei-Manu, W., Langer, R., & Farokhzad, O. C.
Affiliations
  • Harvard–MIT Division of Health Sciences and Technology (US)
  • Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, Harvard−MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, MIT−Harvard Center for Cancer Nanotechnology Excellence, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, and Laboratory of Nanomedicine and...
Corresponding author
Farokhzad, Omid C.
Venue
Nano Letters
Published
2008-07-26
Volume
8
Issue
9
Pages
2906-2912
ISSN
  • 1530-6984 (ISSN-L)
  • 1530-6992
OpenAlex
W2165555463
Cited by
887
References
27
Citations by year
2026: 32 · 2025: 50 · 2024: 57 · 2023: 56 · 2022: 57 · 2021: 72 · 2020: 61 · 2019: 84 · 2018: 54 · 2017: 64 · 2016: 62 · 2015: 43 · 2014: 41 · 2013: 46 · 2012: 47
FWCI
8.62
Type
journal article
Language
en
Open access
closed
Locations
  • Nano Letters (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5u54ca119349-05)
  • National Cancer Institute (CA 119349)
  • National Institute of Biomedical Imaging and Bioengineering (K08EB003647, EB003647)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Engineering › Biomedical Engineering › Innovative Microfluidic and Catalytic Techniques Innovation
  • Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
Keywords
polymeric nanoparticles, microfluidic mixing, flow focusing, nanoprecipitation, drug delivery, controlled drug release, nanoparticle size control, polydispersity, drug loading, nanomedicine
MeSH terms
Particle Size, Polymers, Chemical Precipitation, Microfluidics, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review